Top Diagnostics Startups in 2024

At FIXD, we take the stress and worry out of car problems. FIXD breaks car problems down into simple and understandable terms, so drivers don't get taken advantage of when they go to a repair shop. The FIXD Sensor plugs into the diagnostic port of a driver’s car and communicates via Bluetooth to the FIXD app. Our mission is to create helpful tools and resources for drivers so that they can feel confident and informed whenever they have a car related problem.

Onward Assist is a machine learning platform focused on oncology, that provides decision assistant tools across the clinical process from Diagnostics through to clinical decision making. Our key focus today is in diagnostics assistance in Mammography and Computational pathology (Breast Cancer, Cervical Cancer). Early diagnosis/ prognosis of a cancer type is critical, but the clinician is expected to look at a huge volume of data. The Onward platform provides the tools to help pathologists and radiologists improve productivity and increase throughput.

The HemoLink expands blood testing with a virtually painless, one-step device that people can use at home. Once collected, the tube attached to the device can be placed into existing lab instruments and run for standard diagnostic tests.

Cardiologs is a medical technology company committed to transforming cardiac diagnostics by utilising medical-grade artificial intelligence and cloud technology. from the very early stages, cardiologs partnered with leading cardiology and emergency medicine experts to develop a cutting-edge solution that empowers clinicians worldwide to deliver expert cardiac care faster and more efficiently. the cardiologs ecg analysis solution is built on an ever-growing and proprietary database of more than 1,450,000 recordings and is supported by a number of clinical publications that demonstrate leading diagnostic performance. it was the world’s first medical device powered by deep learning technology to receive regulatory clearance (ce mark in august 2016) and among the first to receive fda clearance (june 2017).

Genetico aims to reduce time to diagnosis and enable new medical discovering in the field of rare and genetic diseases. We are building a clinical genetics workflow software with decision support capabilities aimed at assisting medical geneticists and other stakeholders engaged in the diagnosis and research of rare and genetic diseases. Rare diseases patients on an average wait up to 5-7 years in countries like US and UK to get accurate diagnosis. The problem is even more significant in countries like India with nascent technological infrastructure and awareness to deal with complex genetic conditions. Our efforts are currently focussed on Indian market but have strong global market potential. Customers: Genetic clinics, hospitals, molecular diagnostic labs, clinical research groups and other stakeholders engages in diagnosis and research of rare and genetic diseases. linkedin.com/pulse/rare-disease-indianew-approach-old-problems-arjun-gupta

We are leading a healthcare transformation. Imagine being able to take a drop of blood from your finger, place it into a portable device and in 10-15 minutes, test for a range of disease biomarkers, as accurately as a laboratory test, all for a few dollars. This is the reality our organization will deliver. One where every human being can access, understand, and improve their health.

Clinia is healthcare platform on a mission to transform the conventional patients and healthcare providers experience. Technology is used to make it accessible, efficient and convenient to the masses.

Next generation Point-of-Care Coagulation Viscoelastic Diagnostic CoagCare platform for improved patient outcomes

We develop a cloud platform to manage and analyze spatial omics data, and integrate across different platforms. This brings various challenges, ranging from biology, bioinformatics and machine learning, up to scalable software engineering (HPC, DevOps, deep learning). Our web stack is built in Clojure, whereas our computation engine is Python-based.

IonPath is a Stanford University spin-out with a vision to transform clinical pathology and tumor imaging, a $10B+ market, with the company's novel, highly multi-parametric imaging technology, Multiplexed Ion Beam Imaging (MIBI). IonPath's MIBI is a step-change improvement over the current leading tumor imaging method, immunohistochemistry (IHC). MIBI enables researchers, pathologists, and clinicians to quantitatively analyze and visually display the complex interactions among cancer tumor cells, proteins, antibodies, T-cells, and other relevant features on cells' surfaces and interiors. Understanding these biological players and their interactions should substantially improve cancer research and drug discovery, produce novel diagnostics, and transform the study of disease mechanisms such as cancer ("pathology"). IonPath will develop and commercialize services, instruments, reagents, and ultimately diagnostic tests based on MIBI technology.